Menu
 
Research menu
Jump to menu

Publications:  Dr Michelle Goulart

Kocher HM, Basu B, Froeling FEM, Sarker D, Slater S, Carlin D, deSouza NM, De Paepe KN et al.(2020). Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer. Nature Communications vol. 11, (1)
10.1038/s41467-020-18636-w
https://qmro.qmul.ac.uk/xmlui/handle/123456789/67514
Wu Y, Chang YM, Polton G, Stell AJ, Szladovits B, Macfarlane M, Peters LM, Priestnall SL et al.(2020). Gene Expression Profiling of B Cell Lymphoma in Dogs Reveals Dichotomous Metabolic Signatures Distinguished by Oxidative Phosphorylation. Frontiers in Oncology vol. 10,
10.3389/fonc.2020.00307
Goulart MR, Hlavaty SI, Chang YM, Polton G, Stell A, Perry J, Wu Y, Sharma E et al.(2019). Phenotypic and transcriptomic characterization of canine myeloid-derived suppressor cells. Scientific Reports vol. 9, (1)
10.1038/s41598-019-40285-3
Wu Y, Chang YM, Stell AJ, Priestnall SL, Sharma E, Goulart MR, Gribben J, Xia D et al.(2019). Phenotypic characterisation of regulatory T cells in dogs reveals signature transcripts conserved in humans and mice. Scientific Reports vol. 9, (1)
10.1038/s41598-019-50065-8
Kocher HM, Basu B, Froeling FEM, Sarker D, Slater S, Carlin D, Coetzee C, de Souza N et al.(2019). 700PSTAR-PAC: Phase I clinical trial repurposing all trans retinoic acid (ATRA) as stromal targeting agent in a novel drug combination for pancreatic cancer. Annals of Oncology vol. 30, (Supplement_5)
10.1093/annonc/mdz247.027
Kocher HM, Basu B, Froeling FEM, Sarker D, Slater S, Carlin D, Coetzee C, de Souza N et al. (2019). STAR-PAC: Phase I clinical trial repurposing all trans retinoic acid (ATRA) as stromal targeting agent in a novel drug combination for pancreatic cancer. ANNALS OF ONCOLOGY. vol. 30,
https://qmro.qmul.ac.uk/xmlui/handle/123456789/67573
Goulart MR, Watt J, Siddique I, Lawor R, Dowe T, Bhattacharya S, Crnogorac-Jurcevic T, Allavena P et al. (2019). Abstract 4892: Pentraxin 3: A stromal derived diagnostic biomarker for pancreatic ductal adenocarcinoma. 4892-4892.
10.1158/1538-7445.am2019-4892
https://qmro.qmul.ac.uk/xmlui/handle/123456789/67509
Return to top